Auspex Pharmaceuticals' Debt - III Round

Auspex Pharmaceuticals raised a round of funding on March 12, 2013. Investors include Square 1 Bank.

Auspex Pharmaceuticals is a privately held biopharmaceutical company focused on the use of deuterium in medicinal chemistry, and the treatment of hyperkinetic movement disorders including Huntington's…

Articles about Auspex Pharmaceuticals' Debt - III Round: